1-5 of 5
Rajiv Bassi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells

Zhaojing Zhong, Kyla Driscoll Carroll, Desiree Policarpio, Carla Osborn, Michael Gregory, Rajiv Bassi, Xenia Jimenez, Marie Prewett, Gregory Liebisch, Kris Persaud, Douglas Burtrum, Su Wang, David Surguladze, Stanley Ng, Heather Griffith, Paul Balderes, Jacqueline Doody, Jonathan D. Schwartz, Hagop Youssoufian, Eric K. Rowinsky, Dale L. Ludwig, Larry Witte, Zhenping Zhu, Yan Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (4): 1191–1205.
https://doi.org/10.1158/1078-0432.CCR-09-1634
Published: 15 February 2010
View article titled, Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells
Open the PDF for Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells in another window
Includes: Supplementary data
Journal Articles

Tumors Established with Cell Lines Selected for Oxaliplatin Resistance Respond to Oxaliplatin if Combined with Cetuximab

Marie Prewett, Dhanvanthri S. Deevi, Rajiv Bassi, Fan Fan, Lee M. Ellis, Daniel J. Hicklin, James R. Tonra
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (24): 7432–7440.
https://doi.org/10.1158/1078-0432.CCR-07-1768
Published: 19 December 2007
View article titled, Tumors Established with Cell Lines Selected for Oxaliplatin Resistance Respond to Oxaliplatin if Combined with Cetuximab
Open the PDF for Tumors Established with Cell Lines Selected for Oxaliplatin Resistance Respond to Oxaliplatin if Combined with Cetuximab in another window
Journal Articles

Tumor Growth Inhibition with Cetuximab and Chemotherapy in Non–Small Cell Lung Cancer Xenografts Expressing Wild-type and Mutated Epidermal Growth Factor Receptor

Philipp Steiner, Christopher Joynes, Rajiv Bassi, Su Wang, James R. Tonra, Yaron R. Hadari, Daniel J. Hicklin
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (5): 1540–1551.
https://doi.org/10.1158/1078-0432.CCR-06-1887
Published: 01 March 2007
View article titled, Tumor Growth Inhibition with Cetuximab and Chemotherapy in Non–Small Cell Lung Cancer Xenografts Expressing Wild-type and Mutated Epidermal Growth Factor Receptor
Open the PDF for Tumor Growth Inhibition with Cetuximab and Chemotherapy in Non–Small Cell Lung Cancer Xenografts Expressing Wild-type and Mutated Epidermal Growth Factor Receptor in another window
Journal Articles

Anti-Vascular Endothelial Growth Factor Receptor-1 Antagonist Antibody as a Therapeutic Agent for Cancer

Yan Wu, Zhaojing Zhong, James Huber, Rajiv Bassi, Bridget Finnerty, Erik Corcoran, Huiling Li, Elizabeth Navarro, Paul Balderes, Xenia Jimenez, Henry Koo, Venkata R.M. Mangalampalli, Dale L. Ludwig, James R. Tonra, Daniel J. Hicklin
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (21): 6573–6584.
https://doi.org/10.1158/1078-0432.CCR-06-0831
Published: 03 November 2006
View article titled, Anti-Vascular Endothelial Growth Factor Receptor-1 Antagonist Antibody as a Therapeutic Agent for Cancer
Open the PDF for Anti-Vascular Endothelial Growth Factor Receptor-1 Antagonist Antibody as a Therapeutic Agent for Cancer in another window
Journal Articles

Enhanced Antitumor Activity of Anti-epidermal Growth Factor Receptor Monoclonal Antibody IMC-C225 in Combination with Irinotecan (CPT-11) against Human Colorectal Tumor Xenografts

Marie C. Prewett, Andrea T. Hooper, Rajiv Bassi, Lee M. Ellis, Harlan W. Waksal, Daniel J. Hicklin
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (5): 994–1003.
Published: 01 May 2002
View article titled, Enhanced Antitumor Activity of Anti-epidermal Growth Factor Receptor Monoclonal Antibody IMC-C225 in Combination with Irinotecan (CPT-11) against Human Colorectal Tumor Xenografts
Open the PDF for Enhanced Antitumor Activity of Anti-epidermal Growth Factor Receptor Monoclonal Antibody IMC-C225 in Combination with Irinotecan (CPT-11) against Human Colorectal Tumor Xenografts in another window